Fairbanks Capital Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-553
| Closed | -$20K | – | 52 |
|
2019
Q1 | $20K | Hold |
553
| – | – | 0.02% | 30 |
|
2018
Q4 | $20K | Sell |
553
-941
| -63% | -$34K | 0.02% | 31 |
|
2018
Q3 | $233K | Sell |
1,494
-67
| -4% | -$10.4K | 0.23% | 29 |
|
2018
Q2 | $208K | Hold |
1,561
| – | – | 0.24% | 29 |
|
2018
Q1 | $386K | Hold |
1,561
| – | – | 0.39% | 27 |
|
2017
Q4 | $433K | Buy |
1,561
+7
| +0.5% | +$1.94K | 0.4% | 28 |
|
2017
Q3 | $629K | Hold |
1,554
| – | – | 0.61% | 25 |
|
2017
Q2 | $921K | Hold |
1,554
| – | – | 0.86% | 22 |
|
2017
Q1 | $956K | Hold |
1,554
| – | – | 0.94% | 17 |
|
2016
Q4 | $315K | Sell |
1,554
-14
| -0.9% | -$2.84K | 0.33% | 24 |
|
2016
Q3 | $411K | Buy |
1,568
+14
| +0.9% | +$3.67K | 0.44% | 23 |
|
2016
Q2 | $464K | Buy |
+1,554
| New | +$464K | 0.56% | 20 |
|